Development of pseudobullous morphea and scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa

A scleroderma-like illness that resembles eosinophilic fasciitis has been recently described in patients who have ingested products containing L-tryptophan. This illness, termed the eosinophilia-myalgia syndrome, belongs in the spectrum of scleroderma disorders. We report a case of scleroderma-like illness with unusual pseudobullous morphea and eosinophilia in a patient receiving L-5-hydroxytryptophan and carbidopa